Donisi Health Ltd.

donisihealth.com (under construction)

Formerly ContinUse Biometrics (CU-BX)

High-Tech Company

TECH VERTICALS

AgeTech, Automotive, Biomedical, Digital Health, Healthtech, IoT, Life Sciences, MedTech, Monitoring, Remote Monitoring, Smart Home

General Data

Sector	Digital Health
Company Stage:	Initial Revenues
Established	2013
Number of Employees	12
Reg. Number:	abCDe

DESCRIPTION

Donisi supports patients with CHF and other chronic cardiopulmonary diseases, helping them avoid rehospitalization through simple daily monitoring of key health biomarkers that support timely detection of changes in lung fluid content.

In April 2021, Donisi received FDA clearance for the Gili Pro BioSensor's ability to remotely detect heart rate and respiratory rate simultaneously. The company is now working to expand the clinical scope of the Gili system and plans to submit for clearance for at-home identification of pulmonary congestion later this year.

Donisi has the only clinically validated contact-free technology that can remotely detect signs of pulmonary congestion and additional bio-parameters in the home. Donisi's easy-to-use technology works free from wires, patches, and wearables and is backed by 11 granted patents. It detects and analyzes multiple health bio-indicators simultaneously, providing a platform for managing patients with multiple chronic conditions and co-morbidities, and delivering clinically meaningful insights and notifications of changes in key health indicators.

TECHNOLOGY

At ContinUse Biometrics, they utilize unique and patented methods for Nano-level detection and analysis of vibrations associated with movement of internal organs and of molecules.

	TARGET MARKETS
	Organizations.

	BUSINESS MODEL
	B2B

CONTACT INFO

Expand / Collapse All

Main Address: Tel Aviv, Israel

Address	HaBarzel 32b
City	Tel Aviv
Country	Israel
Zip	6971048

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title	Previous Position
Mr. Yair Brosh	CEO	Pontis (VP, Customer Management)
Mr. Evgeny Beiderman	Co-Founder
Mr. Amit Klir	Co-Founder
Mr. Asher Zelig Polani	Co-Founder	FIS Israel (Senior VP, Marketing and Business Development)
Prof. Zeev Zalevsky	Co-Founder	Wisense (SVP)

	BOARD

Board

Member	Title	Affiliation
abC Defghij	Board Member	CTO & Co-Founder, Continuse
abC Defghij	Board Member	General Partner, Olive Tree
abC Defghij	Board Member	VP, Subsystem Research Lenovo Research
abC Defghij	Board Member	General Partner, OTV
abC Defghij	Board Member	CEO, CU-BX
abC Defghij	Board Member	Director, Chartered Group

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Second Round - Extended

Oct. 16, 2018

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Corporate VC	abCDe

Second Round

Mar. 08, 2018

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe	Led the round
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Investment Company	abCDe	Until 2018, Olive Tree Ventures made several investments as a private micro fund.
abC Defghij	High-Tech Company	abCDe

First Round

Oct. 01, 2014

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Venture Capital Fund	abCDe
abC Defghij	Investment Company	abCDe	Until 2018, Olive Tree Ventures made several investments as a private micro fund.
abC Defghij	Technology Transfer Company	abCDe
abC Defghij	High-Tech Company	abCDe
abC Defghij	Private Investor	abCDe

	R&D Grants

Expand / Collapse All

Round

Date

Stage

Amount

Remarks

R&D Grant

Jan. 19, 2021

R&D

abCDe

Co-op with Dell Technologies (Round Rock, TX).

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Bi-National Fund	abCDe

R&D Grant

Jun. 01, 2019

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

R&D Grant

Jun. 01, 2018

R&D

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	Government Agency	abCDe

	Non-Equity Assistance

Expand / Collapse All

Date

Stage

Remarks

Non-Equity Assistance

Oct. 01, 2015

R&D

Contributor	Type	Amount	Remarks
abC Defghij	Innovation Lab	abCDe

Last Updated:	abCDe
IVC Number:	abCDe